Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Ioanna Dialoupi"'
Autor:
Evangelos Terpos, Maria Gavriatopoulou, Eirini Katodritou, Evdoxia Hatjiharissi, Ioanna Dialoupi, Evgenia Verrou, Kyriaki Manousou, Stavros Gkolfinopoulos, Magdalini Migkou, Sosana Delimpasi, Argiris Symeonidis, Efstathios Kastritis, Meletios A. Dimopoulos
Publikováno v:
HemaSphere, Vol 7, p e43614c0 (2023)
Externí odkaz:
https://doaj.org/article/0757b59f59da40e7b1d70bb3e4fe150c
Autor:
Efstathios Kastritis, Maria Roussou, Maria Gavriatopoulou, Nikolaos Kanellias, Magdalini Migkou, Evangelos Eleutherakis-Papaiakovou, Dimitrios C. Ziogas, Despina Fotiou, Ioannis Ntanasis-Stathopoulos, Ioanna Dialoupi, Stavroula Giannouli, Panagiotis Tsirigotis, Sossana Delimpasi, Despina Mparmparousi, Mairylin Spyropoulou-Vlachou, Aikaterini Xirokosta, Evangelos Terpos, Meletios A. Dimopoulos
Publikováno v:
Blood Advances, Vol 3, Iss 23, Pp 4095-4103 (2019)
Abstract: To gain insights into the characteristics of clinical resistance to lenalidomide, we evaluated the outcomes of 147 consecutive patients with multiple myeloma (MM) homogeneously treated with immunomodulatory imide drugs (IMiDs) pomalidomide
Externí odkaz:
https://doaj.org/article/def3a2f04f314f25bc3c2ba324a9444c
Autor:
Efstathios Kastritis, Ioanna Dialoupi, Maria Gavriatopoulou, Maria Roussou, Nikolaos Kanellias, Despina Fotiou, Ioannis Ntanasis-Stathopoulos, Elektra Papadopoulou, Dimitrios C. Ziogas, Kimon Stamatelopoulos, Efstathios Manios, Argyrios Ntalianis, Evangelos Eleutherakis-Papaiakovou, Asimina Papanikolaou, Magdalini Migkou, Aristea-Maria Papanota, Harikleia Gakiopoulou, Erasmia Psimenou, Maria Irini Tselegkidi, Ourania Tsitsilonis, Ioannis Kostopoulos, Evangelos Terpos, Meletios A. Dimopoulos
Publikováno v:
Blood Advances, Vol 3, Iss 20, Pp 3002-3009 (2019)
Abstract: Bortezomib and dexamethasone with cyclophosphamide (CyBorD) or melphalan (BMDex) are commonly used primary treatments for light-chain (AL) amyloidosis, but limited data exist on bortezomib with immunomodulatory drug combinations. We report
Externí odkaz:
https://doaj.org/article/598bf859355c4662925d925092ed9b85
Autor:
Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Despina Fotiou, Magdalini Migkou, Evangelos Eleutherakis-Papaiakovou, Nikolaos Kanellias, Maria Roussou, Ioanna Dialoupi, Panagiotis Malandrakis, Foteini Theodorakakou, Efstathios Kastritis, Evangelos Terpos, Meletios-Athanasios Dimopoulos
Publikováno v:
HemaSphere, Vol 4, Iss 3, p e381 (2020)
Externí odkaz:
https://doaj.org/article/79979d3dd707430f8d2ad76cc40859e9
Autor:
Georgia Trakada, Despina Fotiou, Anastasios Kallianos, Foteini Theodorakakou, Magdalini Migkou, Maria Gavriatopoulou, Nikolaos Kanellias, Panagiotis Malandrakis, Ioannis Ntanasis-Stathopoulos, Evangelos Eleutherakis-Papaiakovou, Ioanna Dialoupi, Evangelos Terpos, Meletios A. Dimopoulos, Efstathios Kastritis
Publikováno v:
Amyloid. :1-8
Lung involvement in AL amyloidosis is not very common, but post-mortem data and retrospective studies suggest it is likely underrecognized.To perform a comprehensive evaluation of lung function with pulmonary function tests (PFTs) in patients with ne
Autor:
Nikolaos Kanellias, Efstathios Kastritis, Konstantinos Stellos, Ioannis P. Trougakos, Maria Roussou, Kimon Stamatelopoulos, Nikolaos Makris, Despina Fotiou, Efstathios Manios, Ageliki Laina, Eleni-Dimitra Papanagnou, Georgios Georgiopoulos, Meletios A. Dimopoulos, Evangelos Eleutherakis-Papaiakovou, Magdalini Migkou, Maria Kotsopoulou, Evangelos Terpos, Maria Gavriatopoulou, Ioanna Dialoupi
Publikováno v:
Leukemia. 35:1418-1427
Carfilzomib (CFZ) improves survival in relapsed/refractory multiple myeloma but is associated with cardiovascular adverse events (CVAEs). We prospectively investigated the effect of CFZ on endothelial function and associations with CVAEs. Forty-eight
Autor:
Efstathios Kastritis, Charikleia Gakiopoulou, Meletios A. Dimopoulos, Evangelos Eleutherakis-Papaiakovou, Magdalini Migkou, Ioanna Dialoupi, Evangelos Terpos, Ioannis Kostopoulos, Foteini Theodorakakou, Maria Roussou, Despina Fotiou, Anastasia Gatou, Ioannis Ntanasis-Stathopoulos, Nikolaos Kanellias, Panagiotis Malandrakis, Erasmia Psimenou, Smaragdi Marinaki, Maria Gavriatopoulou
Publikováno v:
British Journal of Haematology. 193:113-118
Treatment of the plasma cell clone in monoclonal gammopathy of renal significance (MGRS) is necessary in order to reduce toxic immunoglobulin load to the kidneys and salvage renal function. There are limited data on the use of daratumumab in patients
Autor:
Argyrios Ntalianis, Ioannis Ntanasis-Stathopoulos, Charikleia Gakiopoulou, Meletios A. Dimopoulos, Asimina Papanikolaou, Evangelos Eleutherakis-Papaiakovou, Kimon Stamatelopoulos, Marylin Spyropoulou-Vlachou, Nikolaos Kanellias, Maria Gavriatopoulou, Alexandra Papathoma, Despina Fotiou, Efstathios Kastritis, Erasmia Psimenou, Magdalini Migkou, Eleni A. Karatrasoglou, Maria Roussou, Foteini Theodorakakou, Maria Irini Tselegkidi, Ioanna Dialoupi, Evangelos Terpos
Publikováno v:
Amyloid. 28:3-11
A rapid and deep haematologic response is fundamental in order to improve outcomes of patients with AL amyloidosis. We evaluated the impact of timing and depth of haematologic response at early time points (at 1 and 3 months from the start of therapy
Autor:
Kimon Stamatelopoulos, Dimitrios Delialis, Georgios Georgiopoulos, Maria-Irini Tselegkidi, Foteini Theodorakakou, Ioanna Dialoupi, Dimitrios Bampatsias, Ioannis Petropoulos, Giuseppe Vergaro, Ignatios Ikonomidis, Stavros Tzortzis, Alexandros Briasoulis, John Kanakakis, Ioannis Trougakos, Meletios A. Dimopoulos, Efstathios Kastritis
Publikováno v:
International journal of cardiology. 363
The impact of wild-type transthyretin-related cardiac amyloidosis (ATTRwt) on functional and structural peripheral vascular measures is unknown. In the present study, we explored patterns of vascular dysfunction in patients with ATTRwt in comparison
Autor:
Magdalini Migkou, Maria Roussou, Evangelos Terpos, Maria Gavriatopoulou, Panagiotis Tsirigotis, Meletios A. Dimopoulos, Evangelos Eleutherakis-Papaiakovou, Ioanna Dialoupi, Mairylin Spyropoulou-Vlachou, Nikolaos Kanellias, Sossana Delimpasi, Dimitrios C. Ziogas, Aikaterini Xirokosta, Despina Fotiou, Despina Mparmparousi, Stavroula Giannouli, Efstathios Kastritis, Ioannis Ntanasis-Stathopoulos
Publikováno v:
Blood Advances. 3:4095-4103
To gain insights into the characteristics of clinical resistance to lenalidomide, we evaluated the outcomes of 147 consecutive patients with multiple myeloma (MM) homogeneously treated with immunomodulatory imide drugs (IMiDs) pomalidomide and dexame